Evaluating the Turkish Object Permanence Scale for babies with developmental delays
Reliability and Validity of the Turkish Version of the Object Permanence Scale
This study is testing a new tool to see if it can help understand how babies with motor delays, who are between 7 to 16 months old, develop their understanding of object permanence in a way that fits Turkish culture.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 32 (estimated) |
| Ages | 7 Months to 16 Months |
| Sex | All |
| Sponsor | Tokat Gaziosmanpasa University Academic / other |
| Locations | 1 site (Tokat) |
| Trial ID | NCT05749718 on ClinicalTrials.gov |
What this trial studies
This study focuses on adapting the Object Permanence Scale for Turkish-speaking populations and assessing its reliability and validity. It targets infants aged 7 to 16 months who exhibit motor developmental delays, specifically those who can sit for at least 3 seconds but cannot transition independently between positions. Evaluations will be conducted at baseline and again after one week to ensure consistency in results. The study aims to provide a culturally relevant tool for assessing developmental delays in this age group.
Who should consider this trial
Good fit: Ideal candidates for this study are infants aged 7 to 16 months with specific motor developmental delays.
Not a fit: Patients with severe medical complications or diagnosed conditions such as autism or Down syndrome may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a reliable assessment tool for identifying developmental delays in Turkish infants.
How similar studies have performed: While similar studies have been conducted in other cultural contexts, this specific adaptation for Turkish infants is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 7-16 months, * Sitting for at least 3 seconds but unable to independently switch between sitting and other positions * To show at least one retardation in motor subscale of Bayley III. Exclusion Criteria: * Medical complications (eg, severe visual impairment) limiting participation in assessments; autism, down syndrome, or spinal cord injury; diagnosed uncontrolled seizure disorder; or a neurodegenerative disorder
Where this trial is running
Tokat
- Faculty of Health Sciences, Tokat Gaziosmanpaşa University — Tokat, Turkey (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.